3.24 USD
↘ 0.00 (0.10%)PRE MARKET (AS OF 08:15 PM EDT)
NSRX is currently priced at $3.24. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Aug 13, 2026.
Open?$3.08
High?$3.52
Low?$3.08
Prev. Close?$3.24
Volume?6.7K
Avg. Volume?N/A
VWAP?$3.23
Bid / Ask
Bid?$3.05 × 1.6K
Ask?$3.48 × 0
Spread?$0.43
Midpoint?$3.26
Valuation & Ratios
Market Cap?37.9M
Shares Out?11.7M
Float?6.4M
Float %?55.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?2.49%Low
Short Interest?160.1K
Days to Cover?15.2
Free Float6.4M
Avg Daily Volume10.6K
Settlement Date2026-07-31